000 | 01983 a2200517 4500 | ||
---|---|---|---|
005 | 20250515203038.0 | ||
264 | 0 | _c20100412 | |
008 | 201004s 0 0 eng d | ||
022 | _a1557-3265 | ||
024 | 7 |
_a10.1158/1078-0432.CCR-09-1906 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJacobs, Shana | |
245 | 0 | 0 |
_aPhase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group. _h[electronic resource] |
260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cJan 2010 |
||
300 |
_a750-4 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 |
_aEpothilones _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTumor Burden _xdrug effects |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aFox, Elizabeth | |
700 | 1 | _aKrailo, Mark | |
700 | 1 | _aHartley, Gwen | |
700 | 1 | _aNavid, Fariba | |
700 | 1 | _aWexler, Leonard | |
700 | 1 | _aBlaney, Susan M | |
700 | 1 | _aGoodwin, Anne | |
700 | 1 | _aGoodspeed, Wendy | |
700 | 1 | _aBalis, Frank M | |
700 | 1 | _aAdamson, Peter C | |
700 | 1 | _aWidemann, Brigitte C | |
773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 16 _gno. 2 _gp. 750-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-09-1906 _zAvailable from publisher's website |
999 |
_c19446392 _d19446392 |